Label:Information for the User
Qudix Prolong300 mg prolonged-release tablets EFG
quetiapine
Read this label carefully before starting to take this medicine,because it contains important information for you.
This medication contains a substance called quetiapina. It belongs to a group of medications known as antipsychotics. Qudix Prolong can be used to treat various diseases, such as:
When using quetiapina to treat major depressive episodes in major depressive disorder, this will be taken in addition to another medication that is being used to treat this disease.
Your doctor may continue prescribing quetiapina even when you are feeling better.
If you have any doubts, consult your doctor or pharmacist before taking quetiapine.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Qudix Prolong if:
Inform your doctor immediately if after taking Qudix Prolong you experience any of the following effects:
These conditions may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
Thoughts of suicide and worsening of depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase when you first start treatment, as all these medications take time to become effective, usually around two weeks, but sometimes longer.
These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Drug reaction with eosinophilia and systemic symptoms (DRESS). Generalized rash, elevated body temperature, elevated liver enzymes, blood abnormalities (eosinophilia), swollen lymph nodes, and other affected organs (drug reaction with eosinophilia and systemic symptoms, also known as DRESS).
If you develop these symptoms, stop using quetiapine and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking this medication. You and your doctor should regularly monitor your weight.
Children and adolescents
Qudix Prolong should not be used in children and adolescents under 18 years of age.
Other medications and Qudix Prolong
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take quetiapine if you are using any of the following medications:
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Taking Qudix Prolong with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Do not take quetiapine during pregnancy, unless you have consulted your doctor. Do not use quetiapine if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborn babies of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremor, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
Quetiapine may cause symptoms such as drowsiness, dizziness, or visual disturbances, and may decrease your reaction time. These effects, as well as the underlying condition, may impair your ability to drive vehicles or operate machinery. Therefore, do not drive, operate machinery, or engage in other activities that require special attention, until your doctor assesses your response to this medication.
Effect on Urine Drug Detection Tests
If you are undergoing a urine drug detection test, taking quetiapine may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when using certain analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Qudix Prolong contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and needs, but it will normally be between 150 mg and 800 mg.
Patients with liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Qudix Prolong should not be used in children and adolescents under 18 years of age.
If you take moreQudix Prolongthan you should
If you take more Qudix Prolong than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or nearest hospital immediately. Bring your quetiapine tablets with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to takeQudix Prolong
If you forget a dose, take another as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed doses.
If you interrupt treatment withQudix Prolong
If you stop taking Qudix Prolong abruptly, you may be unable to sleep (insomnia) or may feel nausea, or you may experience headaches, diarrhea, discomfort (vomiting), dizziness, or irritability.
Your doctor may suggest reducing the dose gradually before interrupting treatment.
If you have any doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Unknown(frequency cannot be estimated from available data):
The class of medicines to which quetiapine belongs can cause heart rhythm problems that may be serious and, in severe cases, fatal.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or blood sugar, changes in the amount of thyroid hormones in the blood, increases in liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increases in creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. Prolactin hormone increases may, in rare cases, lead to:
Your doctor may ask you to have blood tests from time to time.
Other side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSpanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and on the blister after the abbreviation “CAD”. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medications.This will help protect the environment.
Tablet core: anhydrous lactose, copolymer of methacrylic acid and ethyl acrylate (1:1) type A, crystalline maltose, magnesium stearate, and talc.
Tablet coating: copolymer of methacrylic acid and ethyl acrylate (1:1) Type A, triethyl citrate.
Appearance of the product and content of the container
The container sizes are:
Qudix Prolong300 mg: 60 tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 - 2nd floor
28023 Aravaca - Madrid
Spain
Responsible for manufacturing:
Pharmathen International S.A.
Industrial Park Sapes, Rodopi Prefecture, Block No.5
69300 Rodopi
Greece
or
Pharmathen S.A.
6, Dervenakion Str
15351 Pallini Attikis
Greece
Last review date of thisleaflet: June 2024
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.